Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 524169, 7 pages
http://dx.doi.org/10.1100/2012/524169
Research Article

Fluorescence Correlation Spectroscopy in Drug Discovery: Study of Alexa532-Endothelin 1 Binding to the Endothelin ETA Receptor to Describe the Pharmacological Profile of Natural Products

1Department of Molecular Pharmacology and Pharmacognosy, Drug Discovery Center, Institute for Scientific Research and High Technology Services, P.O. Box 0843-01103, Panama, Panama
2Smithsonian Tropical Research Institute, P.O. Box 0843-03092, Panama, Panama
3Institute of Biochemistry and Molecular Biology, Rheinische Friedrich-Wilhelms-University, Nussallee 11, 53115 Bonn, Germany
4Department of Plant Biology, University of Illinois at Urbana-Champaign, Room 265, Morrill Hall, 505 S. Goodwin Avenue, Urbana, IL 61801, USA

Received 19 October 2011; Accepted 12 December 2011

Academic Editor: Soichi Miwa

Copyright © 2012 Catherina Caballero-George et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Bohlin, U. Göransson, C. Alsmark, C. Wedén, and A. Backlund, “Natural products in modern life science,” Phytochemistry Reviews, vol. 9, no. 2, pp. 279–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Penesyan, S. Kjelleberg, and S. Egan, “Development of novel drugs from marine surface associated microorganisms,” Marine Drugs, vol. 8, no. 3, pp. 438–459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. K. B. Glaser and A. M. S. Mayer, “A renaissance in marine pharmacology: from preclinical curiosity to clinical reality,” Biochemical Pharmacology, vol. 78, no. 5, pp. 440–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. F. Molinski, D. S. Dalisay, S. L. Lievens, and J. P. Saludes, “Drug development from marine natural products,” Nature Reviews Drug Discovery, vol. 8, no. 1, pp. 69–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Yanagisawa, H. Kurihara, S. Kimura et al., “A novel potent vasoconstrictor peptide produced by vascular endothelial cells,” Nature, vol. 332, no. 6163, pp. 411–415, 1988. View at Google Scholar · View at Scopus
  6. M. Takigawa, T. Sakurai, Y. Kasuya, Y. Abe, T. Masaki, and K. Goto, “Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors,” European Journal of Biochemistry, vol. 228, no. 1, pp. 102–108, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Böhm and J. Pernow, “The importance of endothelin-1 for vascular dysfunction in cardiovascular disease,” Cardiovascular Research, vol. 76, no. 1, pp. 8–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. G. De Nucci, R. Thomas, P. D'Orleans-Juste et al., “Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 24, pp. 9797–9800, 1988. View at Google Scholar · View at Scopus
  9. J. Dupuis, C. A. Goresky, and A. Fournier, “Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ET(B) receptors,” Journal of Applied Physiology, vol. 81, no. 4, pp. 1510–1515, 1996. View at Google Scholar · View at Scopus
  10. S. Motte, K. McEntee, and R. Naeije, “Endothelin receptor antagonists,” Pharmacology and Therapeutics, vol. 110, no. 3, pp. 386–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. W. K. Kroeze, D. J. Sheffler, and B. L. Roth, “G-protein-coupled receptors at a glance,” Journal of Cell Science, vol. 116, no. 24, pp. 4867–4869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Baker, A. Saulière, F. Dumas et al., “Functional membrane diffusion of G-protein coupled receptors,” European Biophysics Journal, vol. 36, no. 8, pp. 849–860, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Hegener, R. Jordan, and H. Häberlein, “Benzodiazepine binding studies on living cells: application of small ligands for fluorescence correlation spectroscopy,” Biological Chemistry, vol. 383, no. 11, pp. 1801–1807, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Vukojević, A. Pramanik, T. Yakovleva, R. Rigler, L. Terenius, and G. Bakalkin, “Study of molecular events in cells by fluorescence correlation spectroscopy,” Cellular and Molecular Life Sciences, vol. 62, no. 5, pp. 535–550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Prenner, A. Sieben, K. Zeller, D. Weiser, and H. Häberlein, “Reduction of high-affinity β2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy,” Biochemistry, vol. 46, no. 17, pp. 5106–5113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Hesterkamp, J. Barker, A. Davenport, and M. Whittaker, “Fragment based drug discovery using fluorescence correlation spectroscopy techniques: challenges and solutions,” Current Topics in Medicinal Chemistry, vol. 7, no. 16, pp. 1582–1591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Caballero-George, J. Bolaños, E. Ochoa, J. L. Carballo, J. A. Cruz, and A. Elizabeth Arnold, “Protocol to isolate sponge-associated fungi from tropical waters and an examination of their cardioprotective potential,” Current Trends in Biotechnology and Pharmacy, vol. 4, no. 4, pp. 881–899, 2010. View at Google Scholar · View at Scopus
  18. D. Marguet, P. F. Lenne, H. Rigneault, and H. T. He, “Dynamics in the plasma membrane: how to combine fluidity and order,” EMBO Journal, vol. 25, no. 15, pp. 3446–3457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Raehal, C. L. Schmid, C. E. Groer, and L. M. Bohn, “Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance,” Pharmacological Reviews, vol. 63, pp. 1001–1019, 2011. View at Google Scholar
  20. J. Meding, L. M. Dinkelborg, M. K. Grieshaber, and W. Semmler, “Targeting of endothelin receptors for molecular imaging of atherosclerosis in rabbits,” Journal of Nuclear Medicine, vol. 43, no. 3, pp. 400–405, 2002. View at Google Scholar · View at Scopus
  21. J. Desmarets, O. Gresser, D. Guedin, and C. Frelin, “Interaction of endothelin-1 with cloned bovine ETA receptors: biochemical parameters and functional consequences,” Biochemistry, vol. 35, no. 47, pp. 14868–14875, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Zemanová, A. Schenk, N. Hunt, G. U. Nienhaus, and R. Heilker, “Endothelin receptor in virus-like particles: ligand binding observed by fluorescence fluctuation spectroscopy,” Biochemistry, vol. 43, no. 28, pp. 9021–9028, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. M. Yu and A. P. Davenport, “Regulation of endothelin receptor expression in vascular smooth-muscle cells,” Journal of Cardiovascular Pharmacology, vol. 26, no. 3, pp. S348–S350, 1995. View at Google Scholar · View at Scopus
  24. O. Meissner and H. Häberlein, “Lateral mobility and specific binding to GABAA receptors on hippocampal neurons monitored by fluorescence correlation spectroscopy,” Biochemistry, vol. 42, no. 6, pp. 1667–1672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. J. Briddon and S. J. Hill, “Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes,” Trends in Pharmacological Sciences, vol. 28, no. 12, pp. 637–645, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. O. Mateo and A. A. De Artiñano, “Highlights on endothelins: a review,” Pharmacological Research, vol. 36, no. 5, pp. 339–351, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. N. J. Freedman, A. S. Ament, M. Oppermann, R. H. Stoffel, S. T. Exum, and R. J. Lefkowitz, “Phosphorylation and desensitization of human endothelin A and B receptors: evidence for G protein-coupled receptor kinase specificity,” Journal of Biological Chemistry, vol. 272, no. 28, pp. 17734–17743, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Okamoto, H. Ninomiya, S. Miwa, and T. Masaki, “Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells,” Journal of Biological Chemistry, vol. 275, no. 9, pp. 6439–6446, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Kenakin, “The classification of seven transmembrane receptors in recombinant expression systems,” Pharmacological Reviews, vol. 48, no. 3, pp. 413–451, 1996. View at Google Scholar · View at Scopus
  30. D. L. Lewis, “Cannabinoid receptor G protein-coupling and inverse agonism,” Current Neuropharmacology, vol. 2, no. 1, pp. 31–36, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Vauquelin and B. von Mentzer, G Protein-Coupled Receptors. Molecular Pharmacology, John Wiley and Sons, West Sussex, England, UK, 2007.